ECOR - צמיחת הכנסות ב-12 חודשים נגררים electroCore, Inc.

electroCore, Inc. (ECOR) neurostimulator production is localized in the US, utilizing automation and insurance warehouses. This daily chart of year-over-year (TTM) sales growth from the GURU.Markets service reflects revenue dynamics, where the parameter value equals 26.70. Non-drug migraine treatment technology ensures stable demand for consumables, while the optimization of the commercial model and insurance payouts strengthen investor confidence in the holding.

This indicator measures revenue dynamics over the last twelve months relative to the same period last year. Investors utilize the TTM sales growth metric to identify phases of market expansion or sector stagnation. An increase in this metric signals business scaling, while a decline indicates a loss of market share. For electroCore, Inc. (ECOR), this trend is driven exclusively by organic growth. Current expansion is supported by the broadening of device insurance coverage and strategic partnerships with US sports organizations.